30
Participants
Start Date
March 28, 2024
Primary Completion Date
March 31, 2025
Study Completion Date
April 1, 2025
BioSpy System
One arm only - in all eligible study patients, the study device will be used. In patients with suspicion of lung cancer a bronchoscope will be inserted to navigate to the lesion where a biopsy sample will be taken for histology analysis. In the current trial, the device will be used to perform electrophysiological measurements in the lesion during bronchoscopic biopsy procedure.
RECRUITING
Royal Brisbane and Women's Hospital, Brisbane
RECRUITING
Marie-Lannelongue Hospital, Le Plessis-Robinson
Lead Sponsor
Sensome
INDUSTRY